234 related articles for article (PubMed ID: 36446655)
1. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Christou-Ergos M; Wiley KE; Leask J
Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.
Nyambayo PPM; Gold MS; Mehta UC; Clarke S; Manyevere R; Chirinda L; Zifamba EN; Nyamandi T
Vaccine; 2023 Oct; 41(45):6700-6709. PubMed ID: 37805357
[TBL] [Abstract][Full Text] [Related]
3. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
Kant A; Jansen J; van Balveren L; van Hunsel F
Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
[TBL] [Abstract][Full Text] [Related]
4. [Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports].
Sawadogo R; Ouoba J; Ilboudo D; Tchoumbi E; Lankoandé-Haro S; Fofana S; Sombié I; Samadoulougou S; Kirakoya-Samadoulougou F
Sante Publique; 2024 Feb; 35(6):149-159. PubMed ID: 38388395
[TBL] [Abstract][Full Text] [Related]
5. Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events.
Noh Y; Ko HY; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Shin JY
Epidemiol Health; 2023; 45():e2023054. PubMed ID: 37309115
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with intention for revaccination among patients with adverse events following immunization.
Muñoz CE; Pham-Huy A; Pernica JM; Boucher FD; De Serres G; Vaudry W; Constantinescu C; Sadarangani M; Bettinger JA; Tapiéro B; Morris SK; McConnell A; Noya F; Halperin SA; Top KA;
Vaccine; 2023 Oct; 41(42):6239-6247. PubMed ID: 37666696
[TBL] [Abstract][Full Text] [Related]
8. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
Jeon M; Kim J; Oh CE; Lee JY
J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
[TBL] [Abstract][Full Text] [Related]
9. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.
Duijster JW; Lieber T; Pacelli S; Van Balveren L; Ruijs LS; Raethke M; Kant A; Van Hunsel F
Front Immunol; 2023; 14():1078736. PubMed ID: 36793715
[TBL] [Abstract][Full Text] [Related]
10. Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan-and the effects of vaccine hesitancy and government policy.
Inokuma Y; Kneller R
Eur J Clin Pharmacol; 2023 Feb; 79(2):269-278. PubMed ID: 36527455
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of adverse events following immunisation: Australia, 2000-2002.
Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021.
Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926650
[TBL] [Abstract][Full Text] [Related]
13. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
14. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
[TBL] [Abstract][Full Text] [Related]
15. Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS).
Shin J; Shim SR; Lee J; Ryu HS; Kim JY
Front Public Health; 2023; 11():1338862. PubMed ID: 38269374
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis.
Kaur U; K L A; Chauhan M; Joshi A; Das A; Kansal S; Jaisawal V; Patwardhan K; Chakrabarti SS
Drug Saf; 2022 Oct; 45(10):1099-1109. PubMed ID: 36030299
[TBL] [Abstract][Full Text] [Related]
19. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
[TBL] [Abstract][Full Text] [Related]
20. Adverse events following immunization: real causality and myths.
Principi N; Esposito S
Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
